nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—Triamcinolone—hematologic cancer	0.219	0.421	CbGbCtD
Terbutaline—BCHE—Irinotecan—hematologic cancer	0.166	0.319	CbGbCtD
Terbutaline—BCHE—Cisplatin—hematologic cancer	0.135	0.26	CbGbCtD
Terbutaline—Isoprenaline—PIK3R1—hematologic cancer	0.00483	0.617	CrCbGaD
Terbutaline—Clenbuterol—TNF—hematologic cancer	0.0015	0.191	CrCbGaD
Terbutaline—Epinephrine—SLC22A1—hematologic cancer	0.000873	0.112	CrCbGaD
Terbutaline—Epinephrine—TNF—hematologic cancer	0.000628	0.0803	CrCbGaD
Terbutaline—Nausea—Cladribine—hematologic cancer	0.000419	0.000936	CcSEcCtD
Terbutaline—Paraesthesia—Mitoxantrone—hematologic cancer	0.000416	0.00093	CcSEcCtD
Terbutaline—Paraesthesia—Irinotecan—hematologic cancer	0.000416	0.00093	CcSEcCtD
Terbutaline—Dizziness—Lenalidomide—hematologic cancer	0.000414	0.000924	CcSEcCtD
Terbutaline—Dyspnoea—Mitoxantrone—hematologic cancer	0.000413	0.000923	CcSEcCtD
Terbutaline—Dyspnoea—Irinotecan—hematologic cancer	0.000413	0.000923	CcSEcCtD
Terbutaline—Asthenia—Bortezomib—hematologic cancer	0.000413	0.000923	CcSEcCtD
Terbutaline—Somnolence—Mitoxantrone—hematologic cancer	0.000412	0.00092	CcSEcCtD
Terbutaline—Somnolence—Irinotecan—hematologic cancer	0.000412	0.00092	CcSEcCtD
Terbutaline—Tachycardia—Cisplatin—hematologic cancer	0.000411	0.000917	CcSEcCtD
Terbutaline—Asthenia—Bleomycin—hematologic cancer	0.00041	0.000915	CcSEcCtD
Terbutaline—Vomiting—Melphalan—hematologic cancer	0.000409	0.000914	CcSEcCtD
Terbutaline—Insomnia—Gemcitabine—hematologic cancer	0.000408	0.000912	CcSEcCtD
Terbutaline—Dizziness—Hydroxyurea—hematologic cancer	0.000408	0.000911	CcSEcCtD
Terbutaline—Hyperhidrosis—Cisplatin—hematologic cancer	0.000407	0.000909	CcSEcCtD
Terbutaline—Rash—Melphalan—hematologic cancer	0.000406	0.000906	CcSEcCtD
Terbutaline—Paraesthesia—Gemcitabine—hematologic cancer	0.000405	0.000906	CcSEcCtD
Terbutaline—Dermatitis—Melphalan—hematologic cancer	0.000405	0.000905	CcSEcCtD
Terbutaline—Asthenia—Vinorelbine—hematologic cancer	0.000403	0.000901	CcSEcCtD
Terbutaline—Dyspnoea—Gemcitabine—hematologic cancer	0.000402	0.000899	CcSEcCtD
Terbutaline—Chest pain—Etoposide—hematologic cancer	0.000402	0.000898	CcSEcCtD
Terbutaline—Nausea—Vinblastine—hematologic cancer	0.000402	0.000897	CcSEcCtD
Terbutaline—Somnolence—Gemcitabine—hematologic cancer	0.000401	0.000897	CcSEcCtD
Terbutaline—Vomiting—Lenalidomide—hematologic cancer	0.000398	0.000888	CcSEcCtD
Terbutaline—Rash—Lenalidomide—hematologic cancer	0.000394	0.000881	CcSEcCtD
Terbutaline—Dermatitis—Lenalidomide—hematologic cancer	0.000394	0.00088	CcSEcCtD
Terbutaline—Vomiting—Hydroxyurea—hematologic cancer	0.000392	0.000876	CcSEcCtD
Terbutaline—Headache—Lenalidomide—hematologic cancer	0.000392	0.000875	CcSEcCtD
Terbutaline—Rash—Hydroxyurea—hematologic cancer	0.000389	0.000869	CcSEcCtD
Terbutaline—Dermatitis—Hydroxyurea—hematologic cancer	0.000388	0.000868	CcSEcCtD
Terbutaline—Hallucination—Prednisone—hematologic cancer	0.000387	0.000864	CcSEcCtD
Terbutaline—Headache—Hydroxyurea—hematologic cancer	0.000386	0.000863	CcSEcCtD
Terbutaline—Asthenia—Thiotepa—hematologic cancer	0.000385	0.00086	CcSEcCtD
Terbutaline—Nausea—Melphalan—hematologic cancer	0.000382	0.000854	CcSEcCtD
Terbutaline—Dizziness—Bortezomib—hematologic cancer	0.000381	0.00085	CcSEcCtD
Terbutaline—Paraesthesia—Cisplatin—hematologic cancer	0.000378	0.000844	CcSEcCtD
Terbutaline—Tachycardia—Etoposide—hematologic cancer	0.000376	0.000841	CcSEcCtD
Terbutaline—Dyspnoea—Cisplatin—hematologic cancer	0.000375	0.000838	CcSEcCtD
Terbutaline—Hyperhidrosis—Etoposide—hematologic cancer	0.000373	0.000833	CcSEcCtD
Terbutaline—Asthenia—Thalidomide—hematologic cancer	0.000372	0.000832	CcSEcCtD
Terbutaline—Dizziness—Vinorelbine—hematologic cancer	0.000372	0.00083	CcSEcCtD
Terbutaline—Nausea—Lenalidomide—hematologic cancer	0.000371	0.00083	CcSEcCtD
Terbutaline—Tachycardia—Prednisolone—hematologic cancer	0.000371	0.000829	CcSEcCtD
Terbutaline—Hyperhidrosis—Prednisolone—hematologic cancer	0.000368	0.000821	CcSEcCtD
Terbutaline—Nausea—Hydroxyurea—hematologic cancer	0.000366	0.000818	CcSEcCtD
Terbutaline—Vomiting—Bortezomib—hematologic cancer	0.000366	0.000818	CcSEcCtD
Terbutaline—Vomiting—Bleomycin—hematologic cancer	0.000363	0.000811	CcSEcCtD
Terbutaline—Rash—Bortezomib—hematologic cancer	0.000363	0.000811	CcSEcCtD
Terbutaline—Dermatitis—Bortezomib—hematologic cancer	0.000362	0.00081	CcSEcCtD
Terbutaline—Drowsiness—Methotrexate—hematologic cancer	0.000362	0.000809	CcSEcCtD
Terbutaline—Flushing—Prednisone—hematologic cancer	0.000361	0.000806	CcSEcCtD
Terbutaline—Headache—Bortezomib—hematologic cancer	0.00036	0.000805	CcSEcCtD
Terbutaline—Rash—Bleomycin—hematologic cancer	0.00036	0.000804	CcSEcCtD
Terbutaline—Dermatitis—Bleomycin—hematologic cancer	0.00036	0.000804	CcSEcCtD
Terbutaline—Asthenia—Carmustine—hematologic cancer	0.000358	0.000799	CcSEcCtD
Terbutaline—Vomiting—Vinorelbine—hematologic cancer	0.000357	0.000798	CcSEcCtD
Terbutaline—Dry mouth—Triamcinolone—hematologic cancer	0.000357	0.000797	CcSEcCtD
Terbutaline—Dizziness—Thiotepa—hematologic cancer	0.000355	0.000793	CcSEcCtD
Terbutaline—Asthenia—Alitretinoin—hematologic cancer	0.000354	0.000792	CcSEcCtD
Terbutaline—Rash—Vinorelbine—hematologic cancer	0.000354	0.000792	CcSEcCtD
Terbutaline—Dermatitis—Vinorelbine—hematologic cancer	0.000354	0.000791	CcSEcCtD
Terbutaline—Headache—Vinorelbine—hematologic cancer	0.000352	0.000786	CcSEcCtD
Terbutaline—Asthenia—Ifosfamide—hematologic cancer	0.00035	0.000782	CcSEcCtD
Terbutaline—Sweating—Methotrexate—hematologic cancer	0.000347	0.000775	CcSEcCtD
Terbutaline—Paraesthesia—Etoposide—hematologic cancer	0.000346	0.000773	CcSEcCtD
Terbutaline—Insomnia—Prednisolone—hematologic cancer	0.000344	0.000768	CcSEcCtD
Terbutaline—Dyspnoea—Etoposide—hematologic cancer	0.000344	0.000768	CcSEcCtD
Terbutaline—Dizziness—Thalidomide—hematologic cancer	0.000343	0.000767	CcSEcCtD
Terbutaline—Somnolence—Etoposide—hematologic cancer	0.000343	0.000766	CcSEcCtD
Terbutaline—Nausea—Bortezomib—hematologic cancer	0.000342	0.000764	CcSEcCtD
Terbutaline—Asthenia—Vincristine—hematologic cancer	0.000341	0.000763	CcSEcCtD
Terbutaline—Paraesthesia—Prednisolone—hematologic cancer	0.000341	0.000763	CcSEcCtD
Terbutaline—Tachycardia—Triamcinolone—hematologic cancer	0.000341	0.000762	CcSEcCtD
Terbutaline—Vomiting—Thiotepa—hematologic cancer	0.000341	0.000762	CcSEcCtD
Terbutaline—Nausea—Bleomycin—hematologic cancer	0.000339	0.000758	CcSEcCtD
Terbutaline—Drowsiness—Epirubicin—hematologic cancer	0.000339	0.000757	CcSEcCtD
Terbutaline—Rash—Thiotepa—hematologic cancer	0.000338	0.000756	CcSEcCtD
Terbutaline—Dermatitis—Thiotepa—hematologic cancer	0.000338	0.000755	CcSEcCtD
Terbutaline—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000338	0.000755	CcSEcCtD
Terbutaline—Headache—Thiotepa—hematologic cancer	0.000336	0.000751	CcSEcCtD
Terbutaline—Nausea—Vinorelbine—hematologic cancer	0.000334	0.000746	CcSEcCtD
Terbutaline—Asthenia—Mitoxantrone—hematologic cancer	0.000332	0.000743	CcSEcCtD
Terbutaline—Asthenia—Irinotecan—hematologic cancer	0.000332	0.000743	CcSEcCtD
Terbutaline—Vomiting—Thalidomide—hematologic cancer	0.00033	0.000737	CcSEcCtD
Terbutaline—Anxiety—Betamethasone—hematologic cancer	0.00033	0.000737	CcSEcCtD
Terbutaline—Anxiety—Dexamethasone—hematologic cancer	0.00033	0.000737	CcSEcCtD
Terbutaline—Dizziness—Carmustine—hematologic cancer	0.00033	0.000736	CcSEcCtD
Terbutaline—Rash—Thalidomide—hematologic cancer	0.000327	0.000731	CcSEcCtD
Terbutaline—Dermatitis—Thalidomide—hematologic cancer	0.000327	0.00073	CcSEcCtD
Terbutaline—Dizziness—Alitretinoin—hematologic cancer	0.000327	0.00073	CcSEcCtD
Terbutaline—Headache—Thalidomide—hematologic cancer	0.000325	0.000726	CcSEcCtD
Terbutaline—Sweating—Epirubicin—hematologic cancer	0.000325	0.000726	CcSEcCtD
Terbutaline—Asthenia—Gemcitabine—hematologic cancer	0.000324	0.000724	CcSEcCtD
Terbutaline—Dizziness—Ifosfamide—hematologic cancer	0.000323	0.000721	CcSEcCtD
Terbutaline—Nausea—Thiotepa—hematologic cancer	0.000319	0.000712	CcSEcCtD
Terbutaline—Vomiting—Carmustine—hematologic cancer	0.000317	0.000708	CcSEcCtD
Terbutaline—Insomnia—Triamcinolone—hematologic cancer	0.000316	0.000707	CcSEcCtD
Terbutaline—Dizziness—Vincristine—hematologic cancer	0.000315	0.000703	CcSEcCtD
Terbutaline—Rash—Carmustine—hematologic cancer	0.000314	0.000702	CcSEcCtD
Terbutaline—Dermatitis—Carmustine—hematologic cancer	0.000314	0.000702	CcSEcCtD
Terbutaline—Vomiting—Alitretinoin—hematologic cancer	0.000314	0.000702	CcSEcCtD
Terbutaline—Paraesthesia—Triamcinolone—hematologic cancer	0.000314	0.000701	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—hematologic cancer	0.000313	0.0007	CcSEcCtD
Terbutaline—Headache—Carmustine—hematologic cancer	0.000312	0.000698	CcSEcCtD
Terbutaline—Dyspnoea—Triamcinolone—hematologic cancer	0.000312	0.000696	CcSEcCtD
Terbutaline—Rash—Alitretinoin—hematologic cancer	0.000311	0.000696	CcSEcCtD
Terbutaline—Dermatitis—Alitretinoin—hematologic cancer	0.000311	0.000695	CcSEcCtD
Terbutaline—Vomiting—Ifosfamide—hematologic cancer	0.00031	0.000693	CcSEcCtD
Terbutaline—Tachycardia—Betamethasone—hematologic cancer	0.00031	0.000692	CcSEcCtD
Terbutaline—Tachycardia—Dexamethasone—hematologic cancer	0.00031	0.000692	CcSEcCtD
Terbutaline—Headache—Alitretinoin—hematologic cancer	0.000309	0.000691	CcSEcCtD
Terbutaline—Nausea—Thalidomide—hematologic cancer	0.000308	0.000689	CcSEcCtD
Terbutaline—Rash—Ifosfamide—hematologic cancer	0.000308	0.000688	CcSEcCtD
Terbutaline—Dermatitis—Ifosfamide—hematologic cancer	0.000307	0.000687	CcSEcCtD
Terbutaline—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000307	0.000685	CcSEcCtD
Terbutaline—Hyperhidrosis—Betamethasone—hematologic cancer	0.000307	0.000685	CcSEcCtD
Terbutaline—Dizziness—Irinotecan—hematologic cancer	0.000306	0.000685	CcSEcCtD
Terbutaline—Vomiting—Vincristine—hematologic cancer	0.000303	0.000676	CcSEcCtD
Terbutaline—Asthenia—Cisplatin—hematologic cancer	0.000302	0.000674	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—hematologic cancer	0.000301	0.000671	CcSEcCtD
Terbutaline—Rash—Vincristine—hematologic cancer	0.0003	0.00067	CcSEcCtD
Terbutaline—Dermatitis—Vincristine—hematologic cancer	0.0003	0.00067	CcSEcCtD
Terbutaline—Headache—Vincristine—hematologic cancer	0.000298	0.000666	CcSEcCtD
Terbutaline—Nausea—Carmustine—hematologic cancer	0.000296	0.000662	CcSEcCtD
Terbutaline—Vomiting—Mitoxantrone—hematologic cancer	0.000295	0.000658	CcSEcCtD
Terbutaline—Vomiting—Irinotecan—hematologic cancer	0.000295	0.000658	CcSEcCtD
Terbutaline—Nausea—Alitretinoin—hematologic cancer	0.000293	0.000655	CcSEcCtD
Terbutaline—Rash—Mitoxantrone—hematologic cancer	0.000292	0.000653	CcSEcCtD
Terbutaline—Rash—Irinotecan—hematologic cancer	0.000292	0.000653	CcSEcCtD
Terbutaline—Dermatitis—Mitoxantrone—hematologic cancer	0.000292	0.000652	CcSEcCtD
Terbutaline—Dermatitis—Irinotecan—hematologic cancer	0.000292	0.000652	CcSEcCtD
Terbutaline—Headache—Mitoxantrone—hematologic cancer	0.00029	0.000649	CcSEcCtD
Terbutaline—Headache—Irinotecan—hematologic cancer	0.00029	0.000649	CcSEcCtD
Terbutaline—Nausea—Ifosfamide—hematologic cancer	0.00029	0.000648	CcSEcCtD
Terbutaline—Anxiety—Prednisone—hematologic cancer	0.000287	0.000642	CcSEcCtD
Terbutaline—Vomiting—Gemcitabine—hematologic cancer	0.000287	0.000641	CcSEcCtD
Terbutaline—Insomnia—Betamethasone—hematologic cancer	0.000287	0.000641	CcSEcCtD
Terbutaline—Insomnia—Dexamethasone—hematologic cancer	0.000287	0.000641	CcSEcCtD
Terbutaline—Paraesthesia—Dexamethasone—hematologic cancer	0.000285	0.000636	CcSEcCtD
Terbutaline—Paraesthesia—Betamethasone—hematologic cancer	0.000285	0.000636	CcSEcCtD
Terbutaline—Rash—Gemcitabine—hematologic cancer	0.000285	0.000636	CcSEcCtD
Terbutaline—Dermatitis—Gemcitabine—hematologic cancer	0.000284	0.000635	CcSEcCtD
Terbutaline—Headache—Gemcitabine—hematologic cancer	0.000283	0.000632	CcSEcCtD
Terbutaline—Nausea—Vincristine—hematologic cancer	0.000283	0.000632	CcSEcCtD
Terbutaline—Flushing—Epirubicin—hematologic cancer	0.000282	0.000631	CcSEcCtD
Terbutaline—Asthenia—Etoposide—hematologic cancer	0.000277	0.000618	CcSEcCtD
Terbutaline—Nausea—Mitoxantrone—hematologic cancer	0.000275	0.000615	CcSEcCtD
Terbutaline—Nausea—Irinotecan—hematologic cancer	0.000275	0.000615	CcSEcCtD
Terbutaline—Tachycardia—Prednisone—hematologic cancer	0.00027	0.000602	CcSEcCtD
Terbutaline—Nausea—Gemcitabine—hematologic cancer	0.000268	0.000599	CcSEcCtD
Terbutaline—Vomiting—Cisplatin—hematologic cancer	0.000268	0.000598	CcSEcCtD
Terbutaline—Hyperhidrosis—Prednisone—hematologic cancer	0.000267	0.000597	CcSEcCtD
Terbutaline—Rash—Cisplatin—hematologic cancer	0.000265	0.000593	CcSEcCtD
Terbutaline—Dermatitis—Cisplatin—hematologic cancer	0.000265	0.000592	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—hematologic cancer	0.000261	0.000584	CcSEcCtD
Terbutaline—Tension—Epirubicin—hematologic cancer	0.00026	0.00058	CcSEcCtD
Terbutaline—Nervousness—Epirubicin—hematologic cancer	0.000257	0.000575	CcSEcCtD
Terbutaline—Dizziness—Etoposide—hematologic cancer	0.000255	0.00057	CcSEcCtD
Terbutaline—Muscle spasms—Epirubicin—hematologic cancer	0.000255	0.000569	CcSEcCtD
Terbutaline—Dizziness—Prednisolone—hematologic cancer	0.000251	0.000562	CcSEcCtD
Terbutaline—Asthenia—Triamcinolone—hematologic cancer	0.000251	0.00056	CcSEcCtD
Terbutaline—Nausea—Cisplatin—hematologic cancer	0.00025	0.000558	CcSEcCtD
Terbutaline—Insomnia—Prednisone—hematologic cancer	0.00025	0.000558	CcSEcCtD
Terbutaline—Paraesthesia—Prednisone—hematologic cancer	0.000248	0.000554	CcSEcCtD
Terbutaline—Vomiting—Etoposide—hematologic cancer	0.000245	0.000548	CcSEcCtD
Terbutaline—Rash—Etoposide—hematologic cancer	0.000243	0.000543	CcSEcCtD
Terbutaline—Dermatitis—Etoposide—hematologic cancer	0.000243	0.000543	CcSEcCtD
Terbutaline—Headache—Etoposide—hematologic cancer	0.000241	0.00054	CcSEcCtD
Terbutaline—Chest pain—Methotrexate—hematologic cancer	0.000241	0.000538	CcSEcCtD
Terbutaline—Tension—Doxorubicin—hematologic cancer	0.00024	0.000537	CcSEcCtD
Terbutaline—Rash—Prednisolone—hematologic cancer	0.00024	0.000536	CcSEcCtD
Terbutaline—Dermatitis—Prednisolone—hematologic cancer	0.000239	0.000535	CcSEcCtD
Terbutaline—Headache—Prednisolone—hematologic cancer	0.000238	0.000532	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—hematologic cancer	0.000238	0.000532	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—hematologic cancer	0.000236	0.000526	CcSEcCtD
Terbutaline—Palpitations—Epirubicin—hematologic cancer	0.000234	0.000523	CcSEcCtD
Terbutaline—Dizziness—Triamcinolone—hematologic cancer	0.000231	0.000517	CcSEcCtD
Terbutaline—Nausea—Etoposide—hematologic cancer	0.000229	0.000512	CcSEcCtD
Terbutaline—Asthenia—Dexamethasone—hematologic cancer	0.000228	0.000509	CcSEcCtD
Terbutaline—Asthenia—Betamethasone—hematologic cancer	0.000228	0.000509	CcSEcCtD
Terbutaline—Nausea—Prednisolone—hematologic cancer	0.000226	0.000505	CcSEcCtD
Terbutaline—Chest pain—Epirubicin—hematologic cancer	0.000225	0.000504	CcSEcCtD
Terbutaline—Anxiety—Epirubicin—hematologic cancer	0.000225	0.000502	CcSEcCtD
Terbutaline—Hyperhidrosis—Methotrexate—hematologic cancer	0.000223	0.000499	CcSEcCtD
Terbutaline—Vomiting—Triamcinolone—hematologic cancer	0.000222	0.000497	CcSEcCtD
Terbutaline—Rash—Triamcinolone—hematologic cancer	0.00022	0.000493	CcSEcCtD
Terbutaline—Dry mouth—Epirubicin—hematologic cancer	0.00022	0.000493	CcSEcCtD
Terbutaline—Dermatitis—Triamcinolone—hematologic cancer	0.00022	0.000492	CcSEcCtD
Terbutaline—Headache—Triamcinolone—hematologic cancer	0.000219	0.000489	CcSEcCtD
Terbutaline—Palpitations—Doxorubicin—hematologic cancer	0.000216	0.000484	CcSEcCtD
Terbutaline—Tachycardia—Epirubicin—hematologic cancer	0.000211	0.000471	CcSEcCtD
Terbutaline—Dizziness—Dexamethasone—hematologic cancer	0.00021	0.000469	CcSEcCtD
Terbutaline—Dizziness—Betamethasone—hematologic cancer	0.00021	0.000469	CcSEcCtD
Terbutaline—Hyperhidrosis—Epirubicin—hematologic cancer	0.000209	0.000467	CcSEcCtD
Terbutaline—Insomnia—Methotrexate—hematologic cancer	0.000209	0.000467	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—hematologic cancer	0.000209	0.000466	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—hematologic cancer	0.000208	0.000464	CcSEcCtD
Terbutaline—Nausea—Triamcinolone—hematologic cancer	0.000208	0.000464	CcSEcCtD
Terbutaline—Paraesthesia—Methotrexate—hematologic cancer	0.000207	0.000463	CcSEcCtD
Terbutaline—Dyspnoea—Methotrexate—hematologic cancer	0.000206	0.00046	CcSEcCtD
Terbutaline—Somnolence—Methotrexate—hematologic cancer	0.000205	0.000459	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—hematologic cancer	0.000204	0.000456	CcSEcCtD
Terbutaline—Vomiting—Betamethasone—hematologic cancer	0.000202	0.000451	CcSEcCtD
Terbutaline—Vomiting—Dexamethasone—hematologic cancer	0.000202	0.000451	CcSEcCtD
Terbutaline—Rash—Dexamethasone—hematologic cancer	0.0002	0.000447	CcSEcCtD
Terbutaline—Rash—Betamethasone—hematologic cancer	0.0002	0.000447	CcSEcCtD
Terbutaline—Dermatitis—Betamethasone—hematologic cancer	0.0002	0.000446	CcSEcCtD
Terbutaline—Dermatitis—Dexamethasone—hematologic cancer	0.0002	0.000446	CcSEcCtD
Terbutaline—Headache—Dexamethasone—hematologic cancer	0.000199	0.000444	CcSEcCtD
Terbutaline—Headache—Betamethasone—hematologic cancer	0.000199	0.000444	CcSEcCtD
Terbutaline—Asthenia—Prednisone—hematologic cancer	0.000198	0.000443	CcSEcCtD
Terbutaline—Insomnia—Epirubicin—hematologic cancer	0.000195	0.000437	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—hematologic cancer	0.000195	0.000436	CcSEcCtD
Terbutaline—Paraesthesia—Epirubicin—hematologic cancer	0.000194	0.000433	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000193	0.000432	CcSEcCtD
Terbutaline—Dyspnoea—Epirubicin—hematologic cancer	0.000193	0.00043	CcSEcCtD
Terbutaline—Somnolence—Epirubicin—hematologic cancer	0.000192	0.000429	CcSEcCtD
Terbutaline—Nausea—Dexamethasone—hematologic cancer	0.000188	0.000421	CcSEcCtD
Terbutaline—Nausea—Betamethasone—hematologic cancer	0.000188	0.000421	CcSEcCtD
Terbutaline—Dizziness—Prednisone—hematologic cancer	0.000183	0.000408	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—hematologic cancer	0.000181	0.000404	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—hematologic cancer	0.00018	0.000401	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—hematologic cancer	0.000178	0.000398	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—hematologic cancer	0.000178	0.000397	CcSEcCtD
Terbutaline—Vomiting—Prednisone—hematologic cancer	0.000176	0.000392	CcSEcCtD
Terbutaline—Rash—Prednisone—hematologic cancer	0.000174	0.000389	CcSEcCtD
Terbutaline—Dermatitis—Prednisone—hematologic cancer	0.000174	0.000389	CcSEcCtD
Terbutaline—Headache—Prednisone—hematologic cancer	0.000173	0.000387	CcSEcCtD
Terbutaline—Asthenia—Methotrexate—hematologic cancer	0.000166	0.00037	CcSEcCtD
Terbutaline—Nausea—Prednisone—hematologic cancer	0.000164	0.000367	CcSEcCtD
Terbutaline—Asthenia—Epirubicin—hematologic cancer	0.000155	0.000346	CcSEcCtD
Terbutaline—Dizziness—Methotrexate—hematologic cancer	0.000153	0.000341	CcSEcCtD
Terbutaline—Vomiting—Methotrexate—hematologic cancer	0.000147	0.000328	CcSEcCtD
Terbutaline—Rash—Methotrexate—hematologic cancer	0.000146	0.000325	CcSEcCtD
Terbutaline—Dermatitis—Methotrexate—hematologic cancer	0.000145	0.000325	CcSEcCtD
Terbutaline—Headache—Methotrexate—hematologic cancer	0.000145	0.000323	CcSEcCtD
Terbutaline—Asthenia—Doxorubicin—hematologic cancer	0.000143	0.00032	CcSEcCtD
Terbutaline—Dizziness—Epirubicin—hematologic cancer	0.000143	0.000319	CcSEcCtD
Terbutaline—Vomiting—Epirubicin—hematologic cancer	0.000137	0.000307	CcSEcCtD
Terbutaline—Nausea—Methotrexate—hematologic cancer	0.000137	0.000306	CcSEcCtD
Terbutaline—Rash—Epirubicin—hematologic cancer	0.000136	0.000304	CcSEcCtD
Terbutaline—Dermatitis—Epirubicin—hematologic cancer	0.000136	0.000304	CcSEcCtD
Terbutaline—Headache—Epirubicin—hematologic cancer	0.000135	0.000302	CcSEcCtD
Terbutaline—Dizziness—Doxorubicin—hematologic cancer	0.000132	0.000295	CcSEcCtD
Terbutaline—Nausea—Epirubicin—hematologic cancer	0.000128	0.000287	CcSEcCtD
Terbutaline—Vomiting—Doxorubicin—hematologic cancer	0.000127	0.000284	CcSEcCtD
Terbutaline—Rash—Doxorubicin—hematologic cancer	0.000126	0.000282	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—hematologic cancer	0.000126	0.000281	CcSEcCtD
Terbutaline—Headache—Doxorubicin—hematologic cancer	0.000125	0.00028	CcSEcCtD
Terbutaline—Nausea—Doxorubicin—hematologic cancer	0.000119	0.000265	CcSEcCtD
Terbutaline—ADRB2—GPCR downstream signaling—LPAR1—hematologic cancer	3.99e-05	0.00158	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—HSPA5—hematologic cancer	3.97e-05	0.00157	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—BRAF—hematologic cancer	3.94e-05	0.00156	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL3RA—hematologic cancer	3.93e-05	0.00156	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HDAC11—hematologic cancer	3.85e-05	0.00153	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CALR—hematologic cancer	3.84e-05	0.00152	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RGS2—hematologic cancer	3.79e-05	0.0015	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—TRIO—hematologic cancer	3.75e-05	0.00149	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—TRH—hematologic cancer	3.75e-05	0.00149	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	3.72e-05	0.00147	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BCR—hematologic cancer	3.69e-05	0.00147	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PDE4B—hematologic cancer	3.68e-05	0.00146	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CNR2—hematologic cancer	3.68e-05	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—FHL2—hematologic cancer	3.65e-05	0.00145	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—LPAR1—hematologic cancer	3.63e-05	0.00144	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—RAC2—hematologic cancer	3.62e-05	0.00143	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AGRN—hematologic cancer	3.58e-05	0.00142	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADCY7—hematologic cancer	3.46e-05	0.00137	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	3.44e-05	0.00137	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HDAC10—hematologic cancer	3.43e-05	0.00136	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMMR—hematologic cancer	3.39e-05	0.00134	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—IDH2—hematologic cancer	3.39e-05	0.00134	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PDE4B—hematologic cancer	3.34e-05	0.00132	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CNR2—hematologic cancer	3.34e-05	0.00132	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—MDM2—hematologic cancer	3.31e-05	0.00131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RAC2—hematologic cancer	3.28e-05	0.0013	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	3.27e-05	0.0013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.2e-05	0.00127	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ARNTL—hematologic cancer	3.19e-05	0.00126	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ARHGEF12—hematologic cancer	3.14e-05	0.00125	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADCY7—hematologic cancer	3.14e-05	0.00125	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTHLH—hematologic cancer	3.13e-05	0.00124	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CA9—hematologic cancer	3.1e-05	0.00123	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ACP5—hematologic cancer	3.1e-05	0.00123	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ARHGEF1—hematologic cancer	3.06e-05	0.00121	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOR2—hematologic cancer	3.06e-05	0.00121	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTGER4—hematologic cancer	3.04e-05	0.00121	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—IDH1—hematologic cancer	2.91e-05	0.00116	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TXN—hematologic cancer	2.88e-05	0.00114	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCC3—hematologic cancer	2.88e-05	0.00114	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTO1—hematologic cancer	2.88e-05	0.00114	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL3—hematologic cancer	2.87e-05	0.00114	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTHLH—hematologic cancer	2.84e-05	0.00113	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SPHK1—hematologic cancer	2.82e-05	0.00112	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTGER4—hematologic cancer	2.76e-05	0.0011	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGRN—hematologic cancer	2.74e-05	0.00109	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL17—hematologic cancer	2.74e-05	0.00109	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—UGT1A1—hematologic cancer	2.71e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCR5—hematologic cancer	2.69e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCR4—hematologic cancer	2.69e-05	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEF1—hematologic cancer	2.65e-05	0.00105	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC22A1—hematologic cancer	2.64e-05	0.00105	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CRABP1—hematologic cancer	2.64e-05	0.00105	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNA13—hematologic cancer	2.6e-05	0.00103	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL3—hematologic cancer	2.59e-05	0.00103	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALOX5—hematologic cancer	2.57e-05	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TIAM1—hematologic cancer	2.56e-05	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—RASGRP1—hematologic cancer	2.51e-05	0.000994	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCL2—hematologic cancer	2.49e-05	0.000989	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NUP98—hematologic cancer	2.49e-05	0.000987	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAK3—hematologic cancer	2.48e-05	0.000985	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCR4—hematologic cancer	2.44e-05	0.000968	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ADCY7—hematologic cancer	2.41e-05	0.000958	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOA3—hematologic cancer	2.41e-05	0.000958	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NUP214—hematologic cancer	2.4e-05	0.000951	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCR7—hematologic cancer	2.38e-05	0.000944	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL13—hematologic cancer	2.38e-05	0.000944	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.37e-05	0.000941	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.37e-05	0.000939	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL3—hematologic cancer	2.35e-05	0.000934	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTR—hematologic cancer	2.35e-05	0.000932	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG2—hematologic cancer	2.35e-05	0.000932	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NCOR2—hematologic cancer	2.35e-05	0.000932	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL3RA—hematologic cancer	2.32e-05	0.00092	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CRKL—hematologic cancer	2.32e-05	0.00092	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ENO2—hematologic cancer	2.3e-05	0.000914	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—RASGRP1—hematologic cancer	2.28e-05	0.000903	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRB2—hematologic cancer	2.25e-05	0.000894	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RGS2—hematologic cancer	2.24e-05	0.000888	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTT1—hematologic cancer	2.23e-05	0.000886	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CMA1—hematologic cancer	2.21e-05	0.000878	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TRH—hematologic cancer	2.21e-05	0.000878	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TRIO—hematologic cancer	2.21e-05	0.000878	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.2e-05	0.000873	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SDC1—hematologic cancer	2.18e-05	0.000866	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SPHK1—hematologic cancer	2.17e-05	0.000859	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGO2—hematologic cancer	2.17e-05	0.000859	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LPAR1—hematologic cancer	2.14e-05	0.00085	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HDAC9—hematologic cancer	2.14e-05	0.00085	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—H3F3B—hematologic cancer	2.12e-05	0.000841	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.09e-05	0.000828	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.06e-05	0.000817	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRB2—hematologic cancer	2.05e-05	0.000812	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CSF2—hematologic cancer	2.01e-05	0.000799	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDE4B—hematologic cancer	1.97e-05	0.000782	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CNR2—hematologic cancer	1.97e-05	0.000782	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.97e-05	0.000781	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF19—hematologic cancer	1.96e-05	0.000776	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—JAK1—hematologic cancer	1.94e-05	0.000771	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PRKCG—hematologic cancer	1.94e-05	0.000771	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RAC2—hematologic cancer	1.94e-05	0.00077	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DKK1—hematologic cancer	1.92e-05	0.000764	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CCL2—hematologic cancer	1.91e-05	0.000758	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT5B—hematologic cancer	1.91e-05	0.000758	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CD44—hematologic cancer	1.86e-05	0.000737	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NQO1—hematologic cancer	1.86e-05	0.000737	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADCY7—hematologic cancer	1.85e-05	0.000735	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CSF2—hematologic cancer	1.83e-05	0.000726	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.82e-05	0.000721	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL2RA—hematologic cancer	1.82e-05	0.00072	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HRAS—hematologic cancer	1.81e-05	0.00072	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—XIAP—hematologic cancer	1.8e-05	0.000715	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRKCG—hematologic cancer	1.77e-05	0.0007	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—JAK1—hematologic cancer	1.77e-05	0.0007	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SMARCA4—hematologic cancer	1.76e-05	0.000697	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SH2B3—hematologic cancer	1.76e-05	0.000697	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYCS—hematologic cancer	1.76e-05	0.000697	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GZMB—hematologic cancer	1.75e-05	0.000693	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSP90AA1—hematologic cancer	1.75e-05	0.000693	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CTNNA1—hematologic cancer	1.71e-05	0.000677	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EIF4EBP1—hematologic cancer	1.7e-05	0.000673	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HSPB1—hematologic cancer	1.7e-05	0.000673	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL3—hematologic cancer	1.7e-05	0.000673	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SDC1—hematologic cancer	1.68e-05	0.000665	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTHLH—hematologic cancer	1.68e-05	0.000665	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL2RA—hematologic cancer	1.65e-05	0.000654	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTGER4—hematologic cancer	1.63e-05	0.000648	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LCK—hematologic cancer	1.62e-05	0.000644	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—H3F3A—hematologic cancer	1.59e-05	0.000631	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.57e-05	0.000623	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTP1—hematologic cancer	1.55e-05	0.000614	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCZ—hematologic cancer	1.55e-05	0.000614	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	1.51e-05	0.0006	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.5e-05	0.000594	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PARP1—hematologic cancer	1.49e-05	0.000593	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	1.47e-05	0.000583	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCB1—hematologic cancer	1.47e-05	0.000582	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	1.44e-05	0.000572	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	1.44e-05	0.000572	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOR1—hematologic cancer	1.42e-05	0.000565	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—hematologic cancer	1.42e-05	0.000565	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CBL—hematologic cancer	1.41e-05	0.000557	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL3—hematologic cancer	1.39e-05	0.000552	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	1.37e-05	0.000545	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	1.37e-05	0.000542	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	1.35e-05	0.000535	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	1.34e-05	0.000533	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SYK—hematologic cancer	1.34e-05	0.000532	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	1.34e-05	0.000532	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	1.33e-05	0.000527	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	1.31e-05	0.000519	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT1—hematologic cancer	1.29e-05	0.000513	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	1.28e-05	0.000507	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	1.28e-05	0.000506	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—hematologic cancer	1.26e-05	0.000499	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	1.26e-05	0.000498	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	1.22e-05	0.000484	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	1.22e-05	0.000482	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRB2—hematologic cancer	1.21e-05	0.00048	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	1.21e-05	0.000479	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	1.21e-05	0.000479	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KITLG—hematologic cancer	1.19e-05	0.000472	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	1.16e-05	0.000461	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.16e-05	0.00046	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	1.15e-05	0.000457	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	1.14e-05	0.000452	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CD86—hematologic cancer	1.11e-05	0.000442	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.11e-05	0.00044	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	1.11e-05	0.00044	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HES1—hematologic cancer	1.1e-05	0.000436	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	1.09e-05	0.000433	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CSF2—hematologic cancer	1.08e-05	0.000429	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF1—hematologic cancer	1.08e-05	0.000429	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	1.06e-05	0.000422	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	1.06e-05	0.000422	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	1.06e-05	0.000422	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—hematologic cancer	1.06e-05	0.000419	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	1.05e-05	0.000417	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	1.05e-05	0.000415	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	1.04e-05	0.000414	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAK1—hematologic cancer	1.04e-05	0.000414	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CREBBP—hematologic cancer	9.8e-06	0.000389	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	9.74e-06	0.000386	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL2—hematologic cancer	9.67e-06	0.000383	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TERT—hematologic cancer	9.63e-06	0.000382	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	9.4e-06	0.000373	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CD—hematologic cancer	9.29e-06	0.000369	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TSC2—hematologic cancer	9.19e-06	0.000364	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALB—hematologic cancer	9.17e-06	0.000364	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	8.84e-06	0.000351	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3R1—hematologic cancer	8.77e-06	0.000348	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	8.75e-06	0.000347	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ESR1—hematologic cancer	8.58e-06	0.00034	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FN1—hematologic cancer	8.48e-06	0.000336	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	8.38e-06	0.000332	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BAD—hematologic cancer	8.38e-06	0.000332	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	8.3e-06	0.000329	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CD80—hematologic cancer	8.13e-06	0.000322	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	8.11e-06	0.000322	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KIT—hematologic cancer	8.11e-06	0.000322	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	8.11e-06	0.000322	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CB—hematologic cancer	8.1e-06	0.000321	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	7.97e-06	0.000316	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	7.77e-06	0.000308	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CREB1—hematologic cancer	7.72e-06	0.000306	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—BRAF—hematologic cancer	7.63e-06	0.000303	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL2—hematologic cancer	7.56e-06	0.0003	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6R—hematologic cancer	7.53e-06	0.000299	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	7.52e-06	0.000298	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	7.18e-06	0.000285	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	7.13e-06	0.000283	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	7.06e-06	0.00028	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTEN—hematologic cancer	7e-06	0.000278	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	6.98e-06	0.000277	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF2—hematologic cancer	6.83e-06	0.000271	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	6.74e-06	0.000267	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—EP300—hematologic cancer	6.67e-06	0.000265	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAK2—hematologic cancer	6.55e-06	0.00026	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	6.42e-06	0.000255	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MDM2—hematologic cancer	6.39e-06	0.000253	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	6.22e-06	0.000247	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MTOR—hematologic cancer	6.22e-06	0.000247	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	5.94e-06	0.000235	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	5.83e-06	0.000231	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	5.77e-06	0.000229	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—hematologic cancer	5.72e-06	0.000227	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL2—hematologic cancer	5.71e-06	0.000227	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—hematologic cancer	5.68e-06	0.000225	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCND1—hematologic cancer	5.57e-06	0.000221	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JUN—hematologic cancer	5.55e-06	0.00022	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	5.38e-06	0.000214	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTEN—hematologic cancer	5.37e-06	0.000213	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	5.26e-06	0.000208	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	5.24e-06	0.000208	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EP300—hematologic cancer	5.12e-06	0.000203	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SRC—hematologic cancer	4.98e-06	0.000198	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CA—hematologic cancer	4.94e-06	0.000196	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	4.85e-06	0.000192	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—hematologic cancer	4.8e-06	0.000191	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRAS—hematologic cancer	4.79e-06	0.00019	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	4.59e-06	0.000182	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYC—hematologic cancer	4.46e-06	0.000177	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	4.45e-06	0.000177	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KRAS—hematologic cancer	4.13e-06	0.000164	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—hematologic cancer	4.03e-06	0.00016	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	3.79e-06	0.00015	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TP53—hematologic cancer	3.67e-06	0.000145	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HRAS—hematologic cancer	3.51e-06	0.000139	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—hematologic cancer	3.36e-06	0.000133	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—hematologic cancer	3.1e-06	0.000123	CbGpPWpGaD
